According to the American Lung Association, the national five-year lung cancer survival rate is about 29.7 percent. The ...

Imaging studies of more than 27,000 adults link a healthier thymus on CT scans with a longer life and lower risks of ...

Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program and translational research in aerodigestive cancers, outlined in an interview ...

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival ...

Amini: The systemic landscape is constantly changing and is very exciting. It will only become more complicated for our ...

A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how ...

This new type of immunotherapy shows promise for treating different cancers including prostate cancer, leukaemia and lung ...

A new wave of immuno-therapies is reshaping the fight against cancer, turning the body’s own immune system into a powerful ...

On Wednesday, March 25, North East resident and lung cancer survivor, Miriam Patterson, will meet with her members of Congress for the American Lung Association’s 11th annual LUNG FORCE Advocacy Day ...

Amini: This varies quite a bit by stage — operable vs. nonoperable — and patients’ performance status and preference. Additionally, more relevant to medical oncology but equally, if not more, ...

LUND, SE / ACCESS Newswire / March 18, 2026 / Cantargia (STO:CANTA) today reported the presentation of new pre-clinical data highlighting how a murine surrogate antibody to nadunolimab, an anti-IL1RAP ...